CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease
Authors
E.E. Abrahamson
S.T. DeKosky
+6 more
M.D. Ikonomovic
W.E. Klunk
C.A. Mathis
E.J. Mufson
S.W. Scheff
J. Wuu
Publication date
1 January 2011
Publisher
Lippincott Williams & Wilkins
Doi
Cite
View
on
PubMed
Abstract
Objective: This study examined the relationship between postmortem precuneus cholinergic enzyme activity, Pittsburgh compound B (PiB) binding, and soluble amyloid-β concentration in mild cognitive impairment (MCI) and Alzheimer disease (AD). Methods: Choline acetyltransferase (ChAT) activity, [3H]PiB binding, and soluble amyloid-β1-42 (Aβ42) concentration were quantified in precuneus tissue samples harvested postmortem from subjects with no cognitive impairment (NCI), MCI, and mild AD and correlated with their last antemortem Mini-Mental State Examination (MMSE) score and postmortem pathologic evaluation according to the National Institute on Aging-Reagan criteria, recommendations of the Consortium to Establish a Registry for Alzheimer\u27s Disease, and Braak stage. Results: Precuneus ChAT activity was lower in AD than in NCI and was comparable between MCI and NCI. Precuneus [3H]PiB binding and soluble Aβ42 levels were elevated in MCI and significantly higher in AD than in NCI. Across all case subjects, reduced ChAT activity was associated with increased [3H]PiB binding, increased soluble Aβ42, lower MMSE score, presence of the APOE®4 allele, and more advanced AD pathology. Conclusions: Despite accumulating amyloid burden, cholinergic enzyme activity is stable in the precuneus during prodromal AD. A decline in precuneus ChAT activity occurs only in clinical AD, when PiB binding and soluble Aβ42 levels are substantially elevated compared with those in MCI. Anti-amyloid interventions in MCI case subjects with a positive PiB PET scan may aid in reducing cholinergic deficits and cognitive decline later in the disease process. Copyright © 2011 by AAN Enterprises, Inc
Similar works
Full text
Available Versions
Sustaining member
University of Miami: Scholarship Miami
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:alma.01UOML_INST:113770946...
Last time updated on 16/01/2024
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1212%2Fwnl.0b013e3...
Last time updated on 02/01/2020
Barrow - St. Joseph's Scholarly Commons
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:scholar.barrowneuro.org:ne...
Last time updated on 23/07/2022